3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Refractory or Relapsed Solid Tumors
1
Recurrence
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Lymphoma, Follicular
1
Leukemia, Myeloid, Acute
1
Leukemia, Biphenotypic, Acute
1
Leukemia
1
Lethal Congenital Contracture Syndrome 2
1
Hematologic Neoplasms
1
Fallopian Tube Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Barrett Esophagus
1
Advanced Breast Cancer
1
Adenocarcinoma Of Esophagus
1
Interventions
Pemetrexed
5
Carboplatin
5
pembrolizumab
4
Nivolumab
4
Cisplatin
4
fludarabine
3
Ipilimumab
3
Cyclophosphamide
3
Radiotherapy, Intensity-Modulated
2
Cerebral Decortication
2
sotorasib
1
ruxolitinib
1
osimertinib
1
olaparib
1
fludarabine phosphate
1
decitabine and cedazuridine drug combination
1
avelumab
1
atezolizumab
1
Platinum
1
LY2940680
1
Influenza Vaccines
1
Gemcitabine
1
Fluorodeoxyglucose F18
1
Blood Component Removal
1
Bevacizumab
1
130-nm albumin-bound paclitaxel
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mesothelioma
×
Itraconazole
×
90 days
×
Clear all
No trials found.